Rituximab in systemic sclerosis: a protocol for systematic review
Background: Systemic sclerosis (SSc) is a clinically complex and challenging disease, the most frequent complication of which is interstitial lung disease, which leads to a worse prognosis. In this situation, cyclophosphamide is considered the criterion standard for treatment, despite the controve...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Outros Autores: | |
| Formato: | article |
| Idioma: | English |
| Publicado em: |
Medicine
|
| Assuntos: | |
| Endereço do item: | https://repositorio.ufrn.br/handle/123456789/55362 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
| id |
ri-123456789-55362 |
|---|---|
| record_format |
dspace |
| spelling |
ri-123456789-553622023-11-16T19:59:53Z Rituximab in systemic sclerosis: a protocol for systematic review Piuvezam, Grasiela Caldas, Marina Maria Vieira de Figueiredo Bezerra Neto, Francisco Alves Azevedo, Kesley Pablo Morais de Pimenta, Isac Davidson Santiago Fernandes Oliveira, Ana Katherine da Silveira Gonçalves de https://orcid.org/0000-0002-2343-7251 cutaneous fibrosis interstitial lung disease rituximab systematic review systemic sclerosis Background: Systemic sclerosis (SSc) is a clinically complex and challenging disease, the most frequent complication of which is interstitial lung disease, which leads to a worse prognosis. In this situation, cyclophosphamide is considered the criterion standard for treatment, despite the controversies regarding its efficacy and toxicity. However, studies using rituximab (RTX) have shown that this drug may be a promising therapeutic option. The objective is to describe a protocol of a systematic review (SR) that analyzes the scientific evidence on the effects of RTX on SSc. Methods: This protocol is guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols. The databases to be searched are PubMed, Scopus, SciELO, LILACS, ScienceDirect, Web of Science, COCHRANE, WHOLIS, PAHO, and EMBASE. The studies that would be included in SR are clinical trials that evaluate the use of RTX in patients with SSc who meet the classification criteria for the disease according to American College of Rheumatology and European League Against Rheumatism (2013) and/or LeRoy criteria will be included in the SR. The data to be extracted are related to the characteristics of the studies: authors, year of publication, study location, type of study, sample size and age, patient characteristics, duration of intervention, therapeutic scheme, follow-up time, main variables, and main results. Results: In our study, we hope to find articles presenting new evidence supporting treatment of SSc with RTX. Conclusions: The SR will present results of scientific evidence for the effects of RTX in SSc. We hope that the results could strengthen clinical decisions for the best treatment of SSc and guide future researches 2023-11-16T19:59:52Z 2023-11-16T19:59:52Z 2019 article PIUVEZAM, Grasiela; AZEVEDO, K. P. M. ; CALDAS, M. M. V. F. ; BEZERRA NETO, F. A. ; PIMENTA, I. D. S. F. ; OLIVEIRA, A. K. S. G. Rituximab in systemic sclerosis: a protocol for systematic review. Medicine, v. 98, p. e17110, 2019. DOI: 10.1097/MD.0000000000017110. Disponível em: https://journals.lww.com/md-journal/fulltext/2019/09200/rituximab_in_systemic_sclerosis__a_protocol_for.18.aspx. Aceso em: 13 nov. 2023. https://repositorio.ufrn.br/handle/123456789/55362 10.1097/MD.0000000000017110 en Attribution 3.0 Brazil http://creativecommons.org/licenses/by/3.0/br/ application/pdf Medicine |
| institution |
Repositório Institucional |
| collection |
RI - UFRN |
| language |
English |
| topic |
cutaneous fibrosis interstitial lung disease rituximab systematic review systemic sclerosis |
| spellingShingle |
cutaneous fibrosis interstitial lung disease rituximab systematic review systemic sclerosis Piuvezam, Grasiela Caldas, Marina Maria Vieira de Figueiredo Bezerra Neto, Francisco Alves Azevedo, Kesley Pablo Morais de Pimenta, Isac Davidson Santiago Fernandes Oliveira, Ana Katherine da Silveira Gonçalves de Rituximab in systemic sclerosis: a protocol for systematic review |
| description |
Background: Systemic sclerosis (SSc) is a clinically complex and challenging disease, the most frequent complication of which is
interstitial lung disease, which leads to a worse prognosis. In this situation, cyclophosphamide is considered the criterion standard for
treatment, despite the controversies regarding its efficacy and toxicity. However, studies using rituximab (RTX) have shown that this
drug may be a promising therapeutic option. The objective is to describe a protocol of a systematic review (SR) that analyzes the
scientific evidence on the effects of RTX on SSc.
Methods: This protocol is guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols. The
databases to be searched are PubMed, Scopus, SciELO, LILACS, ScienceDirect, Web of Science, COCHRANE, WHOLIS, PAHO,
and EMBASE. The studies that would be included in SR are clinical trials that evaluate the use of RTX in patients with SSc who meet
the classification criteria for the disease according to American College of Rheumatology and European League Against Rheumatism
(2013) and/or LeRoy criteria will be included in the SR. The data to be extracted are related to the characteristics of the studies:
authors, year of publication, study location, type of study, sample size and age, patient characteristics, duration of intervention,
therapeutic scheme, follow-up time, main variables, and main results.
Results: In our study, we hope to find articles presenting new evidence supporting treatment of SSc with RTX.
Conclusions: The SR will present results of scientific evidence for the effects of RTX in SSc. We hope that the results could
strengthen clinical decisions for the best treatment of SSc and guide future researches |
| author2 |
https://orcid.org/0000-0002-2343-7251 |
| author_facet |
https://orcid.org/0000-0002-2343-7251 Piuvezam, Grasiela Caldas, Marina Maria Vieira de Figueiredo Bezerra Neto, Francisco Alves Azevedo, Kesley Pablo Morais de Pimenta, Isac Davidson Santiago Fernandes Oliveira, Ana Katherine da Silveira Gonçalves de |
| format |
article |
| author |
Piuvezam, Grasiela Caldas, Marina Maria Vieira de Figueiredo Bezerra Neto, Francisco Alves Azevedo, Kesley Pablo Morais de Pimenta, Isac Davidson Santiago Fernandes Oliveira, Ana Katherine da Silveira Gonçalves de |
| author_sort |
Piuvezam, Grasiela |
| title |
Rituximab in systemic sclerosis: a protocol for systematic review |
| title_short |
Rituximab in systemic sclerosis: a protocol for systematic review |
| title_full |
Rituximab in systemic sclerosis: a protocol for systematic review |
| title_fullStr |
Rituximab in systemic sclerosis: a protocol for systematic review |
| title_full_unstemmed |
Rituximab in systemic sclerosis: a protocol for systematic review |
| title_sort |
rituximab in systemic sclerosis: a protocol for systematic review |
| publisher |
Medicine |
| publishDate |
2023 |
| url |
https://repositorio.ufrn.br/handle/123456789/55362 |
| work_keys_str_mv |
AT piuvezamgrasiela rituximabinsystemicsclerosisaprotocolforsystematicreview AT caldasmarinamariavieiradefigueiredo rituximabinsystemicsclerosisaprotocolforsystematicreview AT bezerranetofranciscoalves rituximabinsystemicsclerosisaprotocolforsystematicreview AT azevedokesleypablomoraisde rituximabinsystemicsclerosisaprotocolforsystematicreview AT pimentaisacdavidsonsantiagofernandes rituximabinsystemicsclerosisaprotocolforsystematicreview AT oliveiraanakatherinedasilveiragoncalvesde rituximabinsystemicsclerosisaprotocolforsystematicreview |
| _version_ |
1784351489196556288 |